Electromed (ELMD) Net Cash Flow Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Electromed | 300.53 Mn | 283.55 Mn | 14.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.33% |
| Dec 31, 2025 | -20.47% |
| Sep 30, 2025 | -30.38% |
| Jun 30, 2025 | -38.00% |
| Mar 31, 2025 | -27.53% |
| Dec 31, 2024 | 15.13% |
| Sep 30, 2024 | -63.77% |
| Jun 30, 2024 | 74.23% |
| Mar 31, 2024 | 31.52% |
| Dec 31, 2023 | 52.92% |
| Sep 30, 2023 | -26.15% |
| Jun 30, 2023 | 8.68% |
| Mar 31, 2023 | -21.04% |
| Dec 31, 2022 | -2.86% |
| Sep 30, 2022 | -64.66% |
| Jun 30, 2022 | -63.95% |
| Mar 31, 2022 | -25.22% |
| Dec 31, 2021 | -20.14% |
| Sep 30, 2021 | 6.72% |
| Jun 30, 2021 | -39.21% |
| Mar 31, 2021 | 13.33% |
| Dec 31, 2020 | -4.93% |
| Sep 30, 2020 | 27.56% |
| Jun 30, 2020 | -4.68% |
| Mar 31, 2020 | 9.94% |
| Dec 31, 2019 | 42.63% |
| Sep 30, 2019 | -22.08% |
| Jun 30, 2019 | -17.92% |
| Mar 31, 2019 | 21.97% |
| Dec 31, 2018 | -33.13% |
| Sep 30, 2018 | -13.26% |
| Jun 30, 2018 | 209.84% |
| Mar 31, 2018 | 19.58% |
| Dec 31, 2017 | 33.30% |
| Sep 30, 2017 | 24.32% |
| Jun 30, 2017 | -11.11% |
| Mar 31, 2017 | 29.53% |
| Dec 31, 2016 | 23.25% |
| Sep 30, 2016 | -2.35% |
| Jun 30, 2016 | 6.26% |
| Mar 31, 2016 | 18.49% |
| Dec 31, 2015 | 23.75% |
| Sep 30, 2015 | -48.46% |